October 2001
Worldwide Biotech;Oct2001, Vol. 13 Issue 10, p3
Trade Publication
Reports that St. Jude Medical Inc. has received Communaute Europeenne Mark approval for its stentless tissue valve, the Toronto Root bioprosthesis.


Related Articles

  • Product Briefs.  // Biomedical Business & Technology;Dec2011, Vol. 34 Issue 12, p24 

    The article offers information on the results of a feasibility study conducted by St. Paul, Minnesota-based St. Jude Medical Inc. for its Portico transcathe-ter aortic heart valve that have demonstrated its efficacy.

  • St. Jude garners CE mark for Trifecta.  // Medical Device Daily;3/3/2010, Vol. 14 Issue 41, p8 

    The article reports on the clinical excellence (CE)-mark approval received by St. Jude Medical for its Trifecta pericardial aortic stented tissue valve.

  • Hundreds of thousands of hearts made healthier in Caguas. Ruano, Lida Estela // Caribbean Business;5/4/2000, Vol. 28 Issue 17, p35 

    Features Saint Jude Medical P.R. Inc., a manufacturing plant in Puerto Rico that produces 90 percent of heart valves used in the United States and more than half of those used worldwide. Total annual heart valve sales of the company; Average cost of the valves; Plant's ISO 9001 certification;...

  • prosthetic heart valve market is dominated by three leading companies: Edwards Lifesciences; St. Jude Medical and Medtronic.  // Biomedical Market Newsletter;8/12/2011, Vol. 21, p764 

    The article reports that the prosthetic heart valve market is dominated by Edwards Lifesciences Corp., St. Jude Medical Inc. and Medtronic Inc. in London, England, according to a report "Prosthetic Heart Valves: A Global Strategic Business Report." It states that the market growth is driven by...

  • St. Jude Medical launches new Trifecta heart valve in Japan.  // Medical Device Daily;4/18/2012, Vol. 16 Issue 75, p1 

    The article reports that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted regulatory approval for the Trifecta aortic stented, pericardial tissue valve from St. Jude Medical. It describes the Trifecta valve for patients with diseased, damaged or malfunctioning heart valves....

  • St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study.  // Biomedical Market Newsletter;11/14/2011, Vol. 21, p594 

    The article reports on the results of a feasibility study for St. Jude Medical Inc.'s Portico Transcatheter Aortic Heart Valve which was presented at the 23rd Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The study reportedly revealed that the device demonstrated...

  • St. Jude Medical Celebrates Two Mlnth Mechanical Heart Valve Implant.  // Biomedical Market Newsletter;4/14/2011, p57 

    The article focuses on the success of mechanical heart valve technology from St. Jude Medical Inc. in Saint Paul, Minnesota. It says that for more than three decades, more than two million patients benefited from the said technology in heart valves prosthetic. According to cardiologist Dr....

  • Key Clinical Data for St. Jude Medical's Structural Heart Technologies Revealed at EuroPCR.  // Biomedical Market Newsletter;5/18/2012, Vol. 21, p1 

    The article informs that clinical data for St. Jude Medical Inc.'s structural heart portfolio is being presented at the EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions. The company will present information on the first-in-man and six-month...

  • Prosthetic Heart Valves Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017.  // Biomedical Market Newsletter;9/26/2011, Vol. 21, p407 

    The article presents the report "Prosthetic Heart Valves Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017" from GlobalData. It provides value data for each segment within the market categories of heart valves and shares data of company in the BRICS countries. It is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics